Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …

The number of individuals referred for coronary artery bypass grafting (CABG) with
preoperative atrial fibrillation (AF) is reported to be 8% to 20%. Atrial fibrillation is a known …

Gastrointestinal (GI) complications are seen in over 50% of ischemic stroke survivors; the
most common complications are dysphagia, constipation, and GI bleeding. The bidirectional …

Introduction Life-long anticoagulation is the recommended management for chronic
thromboembolic pulmonary hypertension (CTEPH). Evidence regarding the use of direct …

A major advancement in the field of medicine has been the introduction and usage of direct
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …

Background Deep vein thrombosis (DVT) is a common condition associated with significant
mortality due to pulmonary embolism. Despite advanced prevention and anticoagulation …

The indications of direct oral anticoagulants (DOACs) have expanded over the past 15
years. DOACs are effective and safe oral anticoagulants associated with lower bleeding …

An increase in rivaroxaban therapies is associated with increased numbers of postoperative
bleeding despite the use of hemostatic sponges, which are currently the gold standard …

Simple Summary Cancer increases the risk of venous thrombosis (VTE) and anticoagulant
therapy is often used to treat this condition. Therefore, it is essential to identify risk factors for …

Methods We carried out a comprehensive search of electronic databases from inception to
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …